Ultrasound for breast cancer screening and staging

Gordon, Paula B.

doi:10.1016/s0033-8389(01)00014-8

Cited by 63 publications

(33 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Early detection and treatment are critical for a favourable diagnosis. Still, palpation and mammography represent the current standard of care, and for the time being mammography is the accepted method for screening and gold standard [1,2,3]. …”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Is the ?blooming sign? a promising additional tool to determine malignancy in MR mammography?

et al. 2004

View full text Add to dashboard Cite

The aim of this study was to evaluate potential diagnostic relevance of blooming effect for verification of suspicious breast lesions in MR mammography (MRM). The MRM examinations of 1035 patients, all following the same imaging protocol (from 1994 to 2001) were retrospectively evaluated by two experienced radiologists in consensus. A total of 817 lesions showed a focal enhancement; of these, 793 were histologically verified after surgical intervention so that 514 malignant and 279 benign lesions could be evaluated. Using a 1.5-T Gyroscan ACS II-imager (Philips, Hamburg, Germany) and a double breast coil with the patient lying in a prone position, 0.1 mmol/kgbw Magnevist (Schering, Berlin, Germany) were injected into the cubital vein to obtain dynamic axial and coronal T1-weighted fast-field-echo images every minute up to 7 min after bolus injection. Blooming sign describes a progradient unsharpness of lesion borders initially sharply shaped and fast enhancing 7 min after bolus injection; 324 of 514 (63.0%) malignant lesions and 41 of 279 (14.7%) benign lesions revealed a blooming sign (sensitivity 63.0%, specificity 85.3%, accuracy 70.9%, positive predictive value 88.8%, negative predictive value 56.0%). Forty-one of 279 benign lesions showed a blooming sign; of these, there were 4 of 86 (4.7%) fibroadenomas, 2 of 21 (9.5%) phylloides tumours, 11 of 38 (28.9%) papillomas, 3 of 9 (33.3%) radial scars, 2 of 19 (10.5%) mastitis, 1 of 4 (25%) galactophoritis, 1 of 3 (33.3%) ADH and 19 of 99 (17.2%) mastopathic proliferations, respectively. Blooming sign is a phenomenon which should be taken into account when diagnosing MR mammographies because it might increase the ability to discriminate uncertain breast lesions; however, this effect can only be used as an additional item to other well-known effects such as plateau, washout and cancer corner.

show abstract

Section: Introductionmentioning

confidence: 99%

“…Ultrasound is a promising adjunct to mammography [3] and increases its sensitivity [8]. 3 Enhancing lesion 1 and 7 min after application of gadolinium 0.1 mmol/kg body weight (subtraction images T1-weighted transversal, technique used as mentioned herein).…”

Section: Introductionmentioning

confidence: 99%

Is the ?blooming sign? a promising additional tool to determine malignancy in MR mammography?

et al. 2004

View full text Add to dashboard Cite

show abstract

“…There is currently no standardized examination technique or interpretation criterion for breast ultrasound. It has a high false positive rate and is less sensitive than breast MRI (Kolb et al, 1998;Buchberger et al, 1999;Gordon, 2002) which might increase the number of biopsies and unnecessary treatment. Based on systematic review, little evidencebased support is found to confirm the well-recognized value of ultrasonography as an adjunct to mammography in the detection of breast cancer in clinical practice and routine use of ultrasonography as an adjunct screening tool in women at average risk for breast cancer is not justified (Flobbe et al, 2002;Gartlehner et al, 2013).…”

Section: Comparison Of Mammography In Combination With Breast Ultrasomentioning

confidence: 99%

Comparison of Mammography in Combination with Breast Ultrasonography Versus Mammography Alone for Breast Cancer Screening in Asymptomatic Women

Boonlikit¹

2013

Asian Pacific Journal of Cancer Prevention

View full text Add to dashboard Cite

“…It is important however to understand that a suspicious finding on mammography requires a more expensive and resource intensive technique such as a vacuum assisted stereotactic biopsy, whereas positive findings on ultrasound can be sampled by simpler faster and less expensive procedures and sometimes by means of fine needle aspiration [25]. The other drawback with the use of ultrasound is time to perform a whole breast ultrasound which has been reported to be between 10 and20 mins per bilateral examinations [24,[26][27][28]. It requires about 20 min performing a meticulous bilateral screening ultrasound; this drawback imposes a limitation of the number of screening studies that can be performed by a radiologist.…”

Section: Breast Mri and Breast Ultrasoundmentioning

confidence: 99%

Screening for Breast Cancer with Mammography: Current Status and An Overview

Shetty

2010

Indian J Surg Oncol

View full text Add to dashboard Cite

This article reviews the current status of Mammographic screening in early detection of Breast cancer. A brief introduction on the global breast cancer burden is followed by an overview of the data proving the benefits of screening mammography in those countries where screening programs are in place. The screening recommendations, the benchmarks of a successful mammographic screening program and an overview of the guidelines that have been implemented for ensuring quality assurance in the USA and Europe are presented. The pertinent aspects of mammographic interpretation and the role of non mammographic screening methods are also discussed.

show abstract

Ultrasound for breast cancer screening and staging

Cited by 63 publications

References 40 publications

Is the ?blooming sign? a promising additional tool to determine malignancy in MR mammography?

Is the ?blooming sign? a promising additional tool to determine malignancy in MR mammography?

Comparison of Mammography in Combination with Breast Ultrasonography Versus Mammography Alone for Breast Cancer Screening in Asymptomatic Women

Screening for Breast Cancer with Mammography: Current Status and An Overview

Contact Info

Product

Resources

About